Encephalomyocarditis virus

Diabetes and Viruses

Volumn 9781461440512, Issue , 2013, Pages 37-48

  Nagafuchi, Seiho ^a   Kurisaki, Hironori ^a   Katsuta, Hitoshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84949179068     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-4051-2_5     Document Type: Chapter

References (50)

1. Bae YS, Eun HM, Yoon JW (1989) Genomic differences between the diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 170:282-287
2. Bae Y, Yoon JW (1993) Determination of diabetogenicity attributable to a single amino acid Ala776, on the polyprotein of encephalomyocarditis virus. Diabetes 42:435-443
3. Baek HS, Yoon JW (1990) Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 64:5708-5715
4. Baek HS, Yoon JW (1991) Direct involvement of macrophages in destruction of b-cells leading to development of diabetes in virus-infected mice. Diabetes 40:1586-1597
5. Choi BK, Cho SH, Bai GH, Kim SJ, Hyun BH, Choe YK, Bae YS (2000) Prevention of encephalomyocarditis virus-induced diabetes by live recombinant mycobacterium bovis Bacillus Calmette-Guerin in susceptible mice. Diabetes 49:1459-1467
6. Chervonsky AV (2010) Influence of microbial environment on autoimmunity. Nat Immunol 11:28-33
7. Christen U, Hintermann E, Holdener M, von Herrath MG (2010) Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty? J Autoimmun 34:38-44
8. Clements GB, Galbraith DN, Taylor KW (1995) Coxsackie B virus infection and onset of child hood diabetes. Lancet 346:221-223
9. Craighead JE, McLane MF (1968) Diabetes mellitus induction in mice by encephalomyocarditis virus. Science 162:913-914
10. Devendra D, Eisenbarth GS (2004) Interferon alpha-a potential link in the pathogenesis of viralinduced type 1 diabetes and autoimmunity. Clin Immunol 111:225-233
11. Eisenbarth GS, Gottlieb PA (2004) Autoimmune polyendocrine syndromes. N Engl J Med 350:2068-2079
12. Eun HM, Bae Y, Yoon JW (1988) Amino acid differences in capsid protein, VP1, between diabetogenic and nondiabetogenic variants of encephalomyocarditis virus. Virology 163:369-373
13. Fehsel AK, Jalowy A, Qi S, Burkart V, Hartmann B, Kolb H (1993) Islet cell DNA is a target of in flammatory attack by nitric oxide. Diabetes 42:496-500
14. Flodström M, Maday A, Balakrishna D, Cleary MM, Yoshimura A, Sarvetnick N (2002) Target cell defense prevents the development of diabetes after viral infection. Nat Immunol 3:373-382
15. Hanafusa T, Imagawa A (2008) Insulitis in human type 1 diabetes. Ann NY Acad Sci 1150:297-299
16. Hirasawa K, Ogiso Y, Takeda M, Lee MJ, Itagaki S, Doi K (1995) Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice. Lab Anim Sci 45:652-656
17. Hirasawa K, Jun HS, Maeda K, Kawaguchi Y, Itagaki S, Mikami T, Baek HS, Doi K, Yoon JW (1997) Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J Virol 71:4024-4031
18. Hover D, Sauter P (2010) Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 6:279-289
19. Huber SA, Babu PG, Craighead JE (1985) Genetic in fluences on the immunologic pathogenesis of encephalomyocarditis (EMC) virus-induced diabetes mellitus. Diabetes 34:1186-1190
20. Jenson AB, Rosenberg HS, Notkins AL (1980) Pancreatic islet-cell damage in children with fatal viral infections. Lancet 316:354-358
21. Jun HS, Kang Y, Notkins AL, Yoon JW (1997) Gain or loss of diabetogenicity result in from a single point mutation in recombinant encephalomyocarditis virus. J Virol 71:9782-9785
22. Jun HS, Kang Y, Yoon HS, Kim KH, Notkins AL, Yoon JW (1998) Determination of encephalomyocarditis viral diabetogenicity by a putative binding site of the viral capsid protein. Diabetes 47:576-582
23. Jun HS, Yoon JW (2001) The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals. Diabetologia 44:271-285
24. Kang Y, Yoon JW (1993) A genetically determined host factor controlling susceptibility to encephalomyocarditis virus-induce diabetes in mice. J Gen Virol 74:1207-1213
25. Kaptur PE, Thomas DC, Giron DJ (1989) The role of interferon in the protection of ICR Swiss male mice by the nondiabetogenic variant of encephalomyocarditis virus against virus-induced diabetes mellitus. J Interferon Res 9:671-678
26. Kawagishi A, Kubosaki A, Takeyama N, Sakudo A, Saeki K, Matsumoto Y, Hayashi T, Onodera T (2003) Analysis of T-cell receptor V b genefrom in fi ltrating T cells in insulitis and myocarditis in encephalomyocarditis virus-infected BALB/C mice. Biochem Biophys Res Commun 310:791-795
27. Kogawa K, Kudoh J, Nagafuchi S, Ohga S, Katsuta H, Ishibashi H, Harada M, Hara T, Shimizu N (2002) Distinct clinical phenotype and immunoreactivity in Japanese siblings with autoimmune polyglandular syndrome type 1 (APS-1) associates with compound heterozygous novel AIRE gene mutations. Clin Immunol 103:277-283
28. Kounoue E, Nagafuchi S, Nakamura M, Nakano S, Koga T, Nakayama M, Mitsuyama M, Niho Y, Takaki R (1987) Encephalomyocarditis (EMC) virus-induced diabetes mellitus prevented by Corynebacterium parvum in mice. Experientia 43:430-431
29. Kounoue E, Izumi K, Ogawa S, Kondo S, Katsuta H, Akashi T, Niho Y, Harada M, Tamiya S, Kurisaki H, Nagafuchi S (2008) The significance of T cells, B cells, antibodies, and macrophages against encephalomyocarditis (EMC)-D virus-induced diabetes in mice. Arch Virol 153:1223-1231
30. McCartney SA, Vermi W, Lonardi S, Rossini C, Otero K, Calderon B, Gilfillan S, Diamond MS, Unanue ER, Colonna M (2011) RNA sensor-induced type 1 IFN prevents diabetes caused by a b-cell tropic virus in mice. J Clin Invest 121:1497-1507
31. Nagafuchi S, Katsuta H, Anzai K (2010) Rituximab, B-lymphocyte depletion, and beta-cell function. N Engl J Med 362:761
32. Nagamine K, Peterson P, Scott HD, Kudoh J, Minoshima S, Heino M, Krohn KJE, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECD gene. Nat Genet 17:393-398
33. Onodera AT, Yoon JW, Brown ES, Notkins AL (1978) Evidencefor a single locus controlling susceptibility to virus-induced diabetes mellitus. Nature 274:693-696
34. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, Becker DJ, Gitelman SE, Goland R, Gottlieb PA, Marks JB, McGee PF, Moran AM, Raskin P, Rodriguez H, Schatz DA, Wherrett D, Wilson DM, Lachin JM, Skyler JS (2009) Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 361:2143-2152
35. Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR, Bleackley RC (1994) DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 37:733-738
36. Racaniello VR (2007) Picornaviridae: the viruses and their replication. In: Knipe DM, Howley PM, Grif fin DE, Lamb RA, Straus SE, Martin MA, Roizman B (eds) Fields virology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 795-838
37. Richardson AJ, Willcox A, Bone AJ, Morgan N, Foulis AK (2011) Immunopathology of the human pancreas in type-I diabetes. Semin Immunopathol 33:9-21
38. Ross ME, Onodera T, Brown KS, Notkins AL (1975) Virus-induced diabetes mellitus. IV. Genetic and environmental factors in fluencing the development of diabetes after infection with the Mvariant of encephalomyocarditis virus. Diabetes 25:190-197
39. Sakaguchi S (2005) Naturally arising Foxp3-expressiong CD25 + CD4 + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345-398
40. Santos CX, Anjos EI, Augusto O (1999) Uric acid oxidation by peroxynitrate: multiple reaction, free radical formation, and amplification of lipid oxidation. Arch Biochem Biophys 372:285-294
41. Smyth DJ, Cooper JD, Bailey R, Field S, Burren O, Smink LJ, Guja C, Ionescu-Tirgoviste C, Widmer B, Dunger DB, Savage DA, Walker NM, Clayton DG, Todd JA (2006) A genome-wide association study of nonsynonymous SNPs identifi es a type 1 diabetes locus in the interferoninduced helicase (IFIH1) region. Nat Genet 38:617-619
42. Takeuchi O, Akira S (2009) Innate immunity to virus infection. Immunol Rev 227:75-86
43. Tanaka S, Nishida Y, Aida K, Maruyama T, Shimada A, Suzuki M, Shimura H, Takizawa S, Takahashi M, Akiyama D, Arai-Yamashita S, Furuya F, Kawaguchi A, Kaneshige M, Katoh R, Endo T, Kobayashi T (2009) Enterovirus infection CXC chemokine ligand 10 (CXCL10), and CXCR3 circuit. Diabetes 58:2285-2291
44. Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H (2011) Enteroviruses in the pathogenesis of type 1 diabetes. Semin Immunopathol 33:45-55
45. Toniolo A, Onodear T, Yoon JW, Notkins AL (1980) Induction of cumulative environmental insults from viruses and chemicals. Nature 288:383-385
46. Yamamoto H, Uchigata Y, Okamoto H (1981) Streptozocin and alloxan induced DNA strand breaks and poly ADP-ribose synthetase in pancreatic islets. Nature 294:284-286
47. Yoon JW, McLintock PR, Onodera T, Notkins AL (1980) Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocariditis virus. J Exp Med 152:878-892
48. Yoon JW, Rodrigues MM, Currier C, Notkins AL (1982) Long-term complications of virus-induced diabetes mellitus in mice. Nature 296:566-569
49. Yoon JW, McClintock PR, BachurskicJ, Longstreth JD, Notkins AL (1985) Virus-induced diabetes mellitus. No evidencefor immune mechanisms in the destruction of b-cell by the D-variant of encephalomyocarditis virus. Diabetes 34:922-923
50. Yoshimura A, Naka T, Kubo M (2007) SOCS proteins, cytokine signaling and immune regulation. Nat Rev Immunol 7:454-465